Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

C008 - Live Demonstration: The State of the Art of Aesthetic Dermatology

Friday, February 16; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Assess the aging face and neck and choose the most appropriate injection techniques.
  • Identify soft tissue fillers and their appropriate uses.
  • Recognize and identify facial and neck anatomy as it relates to the use of cosmetic injections.

Description

This live interactive session will feature experts from around the country demonstrating their techniques and treatment tips with cosmetic injections. Attendees will observe in a live interactive manner precisely how the faculty assess aging faces and go about treating the various areas of the face from brow to neck. Each area will be treated by one of the faculty while another guides the procedure and facilitates dialogue with the audience. There will be discussion and demonstration of the optimal techniques using many of the FDA approved fillers, neuromodulators, and deoxycholic acid.

Disclosures

  • Alster, Tina S., MD: Home Skinovations – C(ST); Merz Aesthetics – C(OB); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sente Labs – I(EQ);
  • Butterwick, Kimberly J., MD: Allergan, Inc – I(Grants/Research Funding); Allergan, Inc. – A(H); Colorescience – A(H); Galderma Laboratories, L.P. – A(H); Merz Pharmaceuticals, LLC – A(H); Revance Therapeutics, Inc. – A(H); ThermiAesthetics – C(H); Valeant Pharmaceuticals International – C(H);
  • Cohen, Joel Lee, MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Galderma USA – C(H), I(Grants/Research Funding); LEO Pharma, US – I(Grants/Research Funding); Merz Pharmaceuticals, LLC – C(H); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sciton Inc. – C(H);
  • Cox, Sue Ellen, MD: Allergan, Inc. – A(H), I(OB); Bayer Pharmaceuticals – I(OB); Candesant Biomedical, Inc. – SH(ST); Cearna, Inc – A(SO); Croma-Pharma GmbH Austria – I(OB); Evolus, Inc. – I(OB); Galderma Laboratories, L.P. – Speaker/Faculty Education(H); Merz Aesthetics – SP(H); Neothetics – I(OB); Revance Therapeutics, Inc. – I(OB); TEOXANE Laboratories – I(OB); TruInject Medical Corporation – SH(ST); Valeant Pharmaceuticals North America LLC – C(H);
  • Donofrio, Lisa M., MD: Allergan, Inc. – A(H), I(OB); American Society of Dermatologic Surgery – B(None Chosen); Canfield Scientific, Inc. – O(H); Fotofinder – I(H); Galderma Laboratories, L.P. – I(None Chosen); Galderma USA – C(H); Journal of Dermatologic Surgery – O(NC), O(None Chosen); Kythera – I(Grants/Research Funding); Mentor Corporation – I(H), I(OB); Merz Pharmaceuticals, LLC – I(OB); Revance Therapeutics, Inc. – I(OB); Sienna Biopharmaceuticals – I(Grants/Research Funding);
  • Fabi, Sabrina G., MD: Alastin Skincare, Inc – A(H); Allergan, Inc – Speaker/Faculty Education(H); Bayer – I(Grants/Research Funding); Colorescience – I(Grants/Research Funding), Speaker/Faculty Education(H); Galderma Laboratories, LP – SP(H); Merz Aesthetics – I(Grants/Research Funding), Speaker/Faculty Education(H); Revance Therapeutics, Inc. – A(H), I(Grants/Research Funding);
  • Goldman, Mitchel Paul, MD: Allergan, Inc. – A(Grants/Research Funding), I(Grants/Research Funding); DUSA Pharmaceuticals, Inc – I(Grants/Research Funding); Galderma USA – C(H), I(Grants/Research Funding); Lumenis – C(Fees), I(EQ); Merz Aesthetics – C(Grants/Research Funding), I(Grants/Research Funding); Sienna Biopharmaceuticals – C(Fees), I(Grants/Research Funding); SkinMedica, Inc. – C(H); SkinMedica, Inc. – I(Grants/Research Funding); Solta Medical – I(Grants/Research Funding); Syneron, Inc. – I(EQ); Valeant Pharmaceuticals International – C(H);
  • Hruza, George J., MD, MBA: Allergan, Inc – A(H); Amgen – SH(NC); Ascend Pharmaceuticals, Inc. – A(H); Express Scripts (formerly Medco Health Solutions) – SH(NC); Johnson & Johnson Consumer Products Company – SH(NC); MD Complete – SH(NC); Merck & Co., Inc. – SH(NC); Pfizer Inc. – SH(NC); Procter & Gamble Company – SH(NC); Pulse Biosciences – A(H), I(Grants/Research Funding); Teva – SH(NC); Unilever – SH(NC);
  • Klein, Lorrie J., MD: Alastin Skincare, Inc – A(SO), SH(NC); Allergan, Inc – SH(NC); Allergan, Inc. – Speaker/Faculty Education(H); Alphaeon – SH(ST); Cearna, Inc – A(SO); Sente Labs – A(H), A(SO), SH(NC);
  • Lawrence, Naomi, MD: no financial relationships exist with commercial interests.
  • Mandy, Stephen Howard, MD: Almirall – C(S); Procter & Gamble Company – C(S); Sinclair Pharma – A(H);
  • Matarasso, Seth L., MD: no financial relationships exist with commercial interests.
  • Monheit, Gary D., MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Alphaeon – I(Grants/Research Funding); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Evolus, Inc. – I(Grants/Research Funding); Galderma Laboratories, L.P. – C(H), I(Grants/Research Funding); Genentech, Inc. – SP(H); Merz Pharmaceuticals, LLC – C(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Suneva Medical, Inc. – C(NC), I(Grants/Research Funding); TEOXANE Laboratories – I(Grants/Research Funding);
  • Palm, Melanie, MD: Allergan, Inc – A(H); AmperSand Biopharmaceutical, LLC – I(Fees); BTL Industries – Speaker/Faculty Education(H); Galderma Laboratories, L.P. – C(H); Kythera – Speaker/Faculty Education(H); Lumenis – SP(H); Lutronics, Inc. – C(OB); Merz Aesthetics – Speaker/Faculty Education(H); Valeant Pharmaceuticals International – C(H);
  • Ross, E. Victor, Jr., MD: Candela Corporation – A(Grants/Research Funding), I(H); Cutera, Inc. – I(EQ), I(Grants/Research Funding); Lumenis – I(EQ), I(H); Sebcaia, Inc – A(H); Syneron, Inc. – I(Grants/Research Funding);
  • Rotunda, Adam M., MD: Kythera – A(ST);
  • Weinkle, Susan H., MD: Allergan, Inc – C(H), I(H); Allergan, Inc. – A(H), SP(H); Alphaeon – I(H); Derm Advance – I(NC), SH(NC); Ethicon, Inc. – A(H), C(H), SP(H); Galderma Laboratories, L.P. – C(H), SP(H); Merz Aesthetics – A(H), C(H), SP(H); Procter & Gamble Company – C(H); Sinclair Pharma – C(H), I(H); TEOXANE Laboratories – I(H);
Schedule
Friday, February 16
1:00 PM
Dr. Matarasso / Introduction
1:10 PM
Dr. Lawrence and Dr. Klein / Upper Face Rejuvenation Treatment of Glabellar Complex; Forehead; Peri-ocular area and Temples
1:30 PM
Dr. Palm and Dr. Cohen / Midface Volume Replacement and Volumizing the Cheeks
1:50 PM
Dr. Mandy and Dr. Donofrio / Peri-oral Rejuvenation and Lip Augmentation
2:10 PM
Dr. Fabi and Dr. Cox / Treatment of the Jawline, Neck, and Masseter Muscle
2:30 PM
Dr. Goldman and Dr. Rotunda / Submental Fat Reduction Without Surgery
2:45 PM
Dr. Butterwick and Dr. Monheit / Non-Facial Aesthetic Treatments
3:05 PM
Dr. Alster and Dr. Ross / Microneedling and PRP
3:25 PM
Dr. Weinkle and Dr. Hruza / Thread Lifts: The New Face of Rhytidectomy
3:50 PM
All faculty / Questions
Event Details
  • Date
    Friday, February 16
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 6D
  • CME Credits
    3.00
  • Type
    Ticketed
    Restricted
Directors/Co-Directors
Speakers
  • Adam M. Rotunda, MD, FAAD
  • E. Victor Ross, Jr., MD, FAAD
  • Gary D. Monheit, MD, FAAD
  • George J. Hruza, MD, MBA, FAAD
  • Joel Lee Cohen, MD, FAAD
  • Kimberly J. Butterwick, MD, FAAD
  • Lisa M. Donofrio, MD, FAAD
  • Lorrie J. Klein, MD, FAAD
  • Melanie Palm, MD, FAAD
  • Mitchel Paul Goldman, MD, FAAD
  • Naomi Lawrence, MD, FAAD
  • Sabrina G. Fabi, MD, FAAD
  • Stephen Howard Mandy, MD, FAAD
  • Sue Ellen Cox, MD, FAAD
  • Susan H. Weinkle, MD, FAAD
  • Tina S. Alster, MD, FAAD